DNA methylation profiling of urological cancers identifies novel cancer-specific and pan-cancer biomarkers, and reveals differentially activated pathways for therapeutic targeting


Por: Lobo, J, Constâncio, V, Gomez, A, Ramalho-Carvalho, J, Carneiro, I, Freitas, R, Esteller, M, Henrique, R and Jerónimo, C

Publicada: 1 sep 2025
Resumen:


Filiaciones:
Lobo, J:
 Portuguese Oncol Inst Porto IPO Porto, Pathol, Porto, Portugal

Constâncio, V:
 Portuguese Oncol Inst Porto IPO Porto, Canc Biol & Epigenet Grp, Porto, Portugal

Gomez, A:
 Univ Vic Cent Univ Catalonia UVic UCC, Biosci, Barcelona, Spain

Ramalho-Carvalho, J:
 Portuguese Oncol Inst Porto IPO Porto, Canc Biol & Epigenet Grp, Porto, Portugal

Carneiro, I:
 Portuguese Oncol Inst Porto IPO Porto, Pathol, Porto, Portugal

Freitas, R:
 Portuguese Oncol Inst Porto IPO Porto, Urol, Porto, Portugal

:
 Josep Carreras Leukemia Res Inst IJC, Canc Epigenet Grp, Barcelona, Spain

Henrique, R:
 Portuguese Oncol Inst Porto IPO Porto, Pathol, Porto, Portugal

Jerónimo, C:
 Portuguese Oncol Inst Porto IPO Porto, Canc Biol & Epigenet Grp, Porto, Portugal
ISSN: 09456317





Virchows Archiv
Editorial
Springer Verlag, ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES, Alemania
Tipo de documento: Meeting Abstract
Volumen: 487 Número:
Páginas: 153-153
WOS Id: 001583403101143

MÉTRICAS